Cargando…
Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors
The CRISPR-associated Cas9 system can modulate disease-causing alleles both in vivo and ex vivo, raising the possibility of therapeutic genome editing. In addition to gene targeting, epigenetic modulation by the catalytically inactive dCas9 may also be a potential form of cancer therapy. Granulin (G...
Autores principales: | Wang, Hong, Guo, Rui, Du, Zhonghua, Bai, Ling, Li, Lingyu, Cui, Jiuwei, Li, Wei, Hoffman, Andrew R., Hu, Ji-Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849805/ https://www.ncbi.nlm.nih.gov/pubmed/29858058 http://dx.doi.org/10.1016/j.omtn.2018.01.002 |
Ejemplares similares
-
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
por: Moses, Colette, et al.
Publicado: (2018) -
CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation
por: Cai, Ruijie, et al.
Publicado: (2023) -
Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer
por: Waryah, Charlene, et al.
Publicado: (2023) -
Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing
por: Moses, C., et al.
Publicado: (2020) -
Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system
por: Garcia-Bloj, Benjamin, et al.
Publicado: (2016)